In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
doctor and patients
In the Clinic
How a Watch-and-Wait Approach May Help People with Rectal Cancer Preserve Their Quality of Life

Discover how a watch-and-wait approach to treating rectal cancer can help people avoid surgery and preserve normal body functions.
Microscopic image of prostate cancer cells in culture.
Q&A
Genetic Finding Can Guide Immunotherapy for Prostate Cancer

Genetic sequencing of prostate tumors can identify men who should receive immunotherapy drugs.
John Mendelsohn
Feature
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer

The scientific world lost one of its greats this week. Here, we reflect on his influence.
Illustration of DNA base pairs
In the Lab
What Was MSK’s Role in TCGA, the Groundbreaking Cancer Genomic Study?

The multicenter project, which yielded dozens of scientific papers on more than 30 different kinds of cancer, has officially drawn to a close.
2018
Roundup
Top 10 Stories of 2018, Cancer Research Edition

Take a look back at some of the year’s biggest news in cancer research.
Vinny as Santa with MSK nurses
Feature
Here Comes Santa Claus: How an MSK Locksmith Delivers Joy at Christmas

Every December for almost 30 years, MSK locksmith Vincent “Vinny” Fortunato has dressed up as Santa Claus to spread holiday cheer to patients and their family members.
Miguel Perales and his patient Jay
Feature
How MSK Donors Drive Early Research to Help People with Cancer

Developing new ways to fight cancer is complex. At Memorial Sloan Kettering, patients, doctors, and scientists all participate in research that leads to new discoveries.
electron micrograph of a natural killer cell
In the Lab
Drugs That Stall — But Don’t Kill — Cancer Cells Are an Untapped Resource, Study Suggests

A drug combination that halts tumor cell division can stir the immune system into taking action.
Kirt Robinson
In the Clinic
Kirt’s Story: How a Clinical Trial for a Rare Tumor Gave Me a New Lease on Life

A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.
Targeted Therapy, Sorafenib, Shows Promise as First-Line Treatment for Previously Untreatable Rare Tumors

In patients with progressive, refractory, or symptomatic desmoid tumors, sorafenib (Nexavar®) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective in slowing disease progression.